News Conference News ACC 2025 By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE Michael O'Riordan March 31, 2025
News Conference News ACC 2024 Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC Michael O'Riordan April 08, 2024
News Conference News ACC 2023 Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA Yael L. Maxwell March 09, 2023
News Conference News ACC 2023 PULSED AF ‘Strengthens the Case’ for Pulsed-Field Ablation in AF Todd Neale March 06, 2023
News Conference News ACC 2021 Low 1-Year Stroke Risk After Commercial Watchman Use Todd Neale May 15, 2021
News Conference News ACC 2021 ‘Enormous’ QoL Improvements With Mavacamten in HCM Shelley Wood May 15, 2021
News Conference News ACC 2020 LAAO Registry: Safety of Watchman Looks Good in First Years of Rollout Todd Neale April 06, 2020
News Conference News ACC 2020 Renal Denervation Lowers BP in Pivotal SPYRAL HTN-OFF MED Trial Todd Neale March 30, 2020
News Conference News ACC 2020 Early Data Support TAVR in Bicuspid Valves, but Questions Remain Michael O'Riordan March 29, 2020
News Conference News ACC 2019 COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions Shelley Wood March 17, 2019
News Conference News ACC 2019 ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend Shelley Wood March 11, 2019
News Conference News ACC 2018 My Takeaways From ACC 2018: Everyone Missing From Clinical Trials, Please Stand Up Shelley Wood March 27, 2018
News Conference News ACC 2018 PFO Closure Guided by High-Risk Features on Echo Shows Benefit in DEFENSE-PFO Shelley Wood March 15, 2018
News Conference News ACC 2018 Bad BVS News: Analysis Points to Fast Reaction by Interventionalists to Absorb Safety Issues Michael O'Riordan March 11, 2018
News Conference News ACC 2017 TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes Shelley Wood March 24, 2017
News Conference News ACC 2017 ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience Michael O'Riordan March 18, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Conference News ACC 2016 New Insights Into MitraClip Performance in Both Functional and Degenerative MR Subtypes, as Use Expands Shelley Wood April 12, 2016
News Conference News ACC 2016 Cardioband Transcatheter Mitral Annulus Repair Appears Safe, Effective in Functional MR Shelley Wood April 07, 2016
News Conference News ACC 2016 New-Generation Watchman FLX Device Pulled From European Shelves Over Embolism Concerns Todd Neale April 04, 2016